首页> 外国专利> - - NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY

- - NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY

机译:--基于纳米颗粒的肿瘤药物递送

摘要

The present invention provides an aqueous tumor-targeted liposomal nanoparticle composition comprising an aqueous dispersion of liposomal nanoparticles. Preferably, the nanoparticles encapsulate an anti-cancer chemotherapeutic agent that can be added to the pre-formed liposome composition or incorporated into the liposome upon formation of the liposome. Liposomal nanoparticles contain regime-targeting lipids in the form of liposomes dispersed in an aqueous carrier in admixture with one or more micelles or vesicle-forming lipid materials. Preferred tumor-targeted liposomal nanoparticle compositions comprise (a) a regimen-targeting lipid component; (b) zwitterionic lipid components; (c) an amino-substituted lipid component; (d) a neutral lipid component; And (e) a polyethylene glycol-conjugated lipid component. The regumain-targeting lipid component comprises a hydrophobic lipid moiety attached by a covalent bond to a regmain-binding moiety.
机译:本发明提供了包含脂质体纳米颗粒的水性分散体的靶向肿瘤的脂质体水性纳米颗粒组合物。优选地,纳米颗粒包封抗癌化学治疗剂,其可被添加到预形成的脂质体组合物中或在脂质体形成时被掺入脂质体中。脂质体纳米颗粒包含脂质体形式的以方案为目标的脂质,脂质体分散在水性载体中,与一种或多种胶束或形成囊泡的脂质材料混合。优选的靶向肿瘤的脂质体纳米颗粒组合物包含(a)靶向方案的脂质组分; (b)两性离子脂质成分; (c)氨基取代的脂质组分; (d)中性脂质成分; (e)聚乙二醇共轭脂质成分。靶向reggumain的脂质组分包含通过共价键连接至regmain结合部分的疏水脂质部分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号